Saturn V Capital Management LP MLTX Holdings History
Saturn V Capital Management LP's MoonLake Immunotherapeutics Holding Summary
As of 2025-03-31, Saturn V Capital Management LP held 343,849.00 shares of MoonLake Immunotherapeutics(MLTX), totaling $13.43 Mil. This investment constitutes 6.78% of their stock portfolio, and Saturn V Capital Management LP now holds 0.54% of the outstanding MoonLake Immunotherapeutics(MLTX) stock.
The initial trade took place in 2024Q3. And since then Saturn V Capital Management LP has made 2 purchases of MLTX, at an average price of $47.43, for a total of 346,111.00 shares. In addition, there have been 1 sales at an average price of $43.09 for 2,262.00 shares. Based on historical transaction data and MLTX's current price of $55.03, Saturn V Capital Management LP's estimated gain on his MLTX holdings is $2.60 Mil, reflecting a 15.86% gain to date.
Saturn V Capital Management LP MLTX ($55.03) Holding Chart
Saturn V Capital Management LP MLTX ($55.03) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
